Compound Evidence File
#EC-2026-0907
Anastrozole (Arimidex) Raw
Filed under Raw Materials. The bureau holds 72 laboratory returns for this compound from 23 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
23 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 6 | 9.9 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| HomopeptideCASE #VI-2026-0760 | A | 5 | 9.9 | 9.9 | 9.9 | 25 May 2026 | 25 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 7 | 8.7 | 7.8 | 9.8 | 25 May 2026 | 25 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 5 | 8.7 | 8.3 | 9.5 | 24 May 2026 | 24 May 2026 |
| Hangzhou Mandy BiotechnologyCASE #VI-2026-0695 | X | 1 | 8.7 | 8.7 | 8.7 | 2 Apr 2025 | 2 Apr 2025 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 5 | 8.6 | 7.6 | 10.0 | 24 May 2026 | 24 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 7 | 8.4 | 7.6 | 9.7 | 24 May 2026 | 24 May 2026 |
| Golden EagleCASE #VI-2026-0680 | X | 1 | 8.4 | 8.4 | 8.4 | 6 May 2025 | 6 May 2025 |
| NextGen HealthCASE #VI-2026-0604 | X | 1 | 8.3 | 8.3 | 8.3 | 7 May 2025 | 7 May 2025 |
| Zen PeptidesCASE #VI-2026-0940 | X | 1 | 8.3 | 8.3 | 8.3 | 25 Apr 2025 | 25 Apr 2025 |
| Yiwu Aozuo Trading CoCASE #VI-2026-0798 | X | 7 | 7.9 | 7.1 | 9.0 | 13 Feb 2025 | 17 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 4 | 7.8 | 7.2 | 8.7 | 21 May 2026 | 21 May 2026 |
| BeiBangAnCASE #VI-2026-0899 | X | 3 | 7.6 | 5.4 | 9.8 | 9 Jun 2025 | 23 May 2026 |
| Atomik LabzCASE #VI-2026-0327 | X | 4 | 7.4 | 6.7 | 8.2 | 17 Dec 2024 | 23 May 2026 |
| Orbitrex PeptidesCASE #VI-2026-0812 | X | 1 | 7.3 | 7.3 | 7.3 | 20 Jun 2025 | 20 Jun 2025 |
| Shanghai ERP peptide BiotechnologyCASE #VI-2026-0500 | X | 1 | 6.8 | 6.8 | 6.8 | 7 May 2025 | 7 May 2025 |
| Qingdao Hongshengda TradingCASE #VI-2026-0334 | X | 1 | 6.6 | 6.6 | 6.6 | 8 Jul 2025 | 8 Jul 2025 |
| Pura PeptidesCASE #VI-2026-0307 | X | 1 | 6.1 | 6.1 | 6.1 | 20 Jun 2025 | 20 Jun 2025 |
| Qing Li PeptideCASE #VI-2026-0469 | X | 9 | 6.0 | 3.6 | 8.4 | 25 Apr 2025 | 23 May 2026 |
| Mix PeptidesCASE #VI-2026-0699 | X | 1 | 5.0 | 5.0 | 5.0 | 14 Jan 2025 | 14 Jan 2025 |
| Pharma Grade PeptidesCASE #VI-2026-0208 | X | 1 | 3.7 | 3.7 | 3.7 | 17 Dec 2024 | 17 Dec 2024 |
| Wolverine PeptidesCASE #VI-2026-0262 | X | 1 | 3.2 | 3.2 | 3.2 | 2 Apr 2025 | 2 Apr 2025 |
| WllyBIOCASE #VI-2026-0470 | X | 1 | 2.2 | 2.2 | 2.2 | 16 Mar 2025 | 16 Mar 2025 |
Open any subject to view the batch-level evidence for Anastrozole (Arimidex) Raw alone.